Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Germ Cell Tumors (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Germ Cell Tumors (Oncology) - Drugs in Development, 2021 SUMMARY Germ Cell Tumors (Oncology) - Drugs in Development, 2021 provides an overview of the Germ Cell Tumors pipeline landscape. The report pr...
April 2021
35 pages
Glycoprotein 140 (gp140) - Drugs in Development, 2021
US$ 3,000.00
Glycoprotein 140 (gp140) - Drugs in Development, 2021 SUMMARY Glycoprotein 140 (gp140) - Drugs in Development, 2021 provides in depth analysis on Glycoprotein 140 (gp140) targeted pipeline therapeutic...
April 2021
35 pages
Heat Shock Protein 70 (HSP70) - Drugs in Development, 2021
US$ 3,000.00
Heat Shock Protein 70 (HSP70) - Drugs in Development, 2021 SUMMARY Heat Shock Protein 70 (HSP70) - Drugs in Development, 2021 provides in depth analysis on Heat Shock Protein 70 (HSP70) targeted pipel...
April 2021
45 pages
Heat Shock Protein 90 (HSP90) - Drugs in Development, 2021
US$ 3,000.00
Heat Shock Protein 90 (HSP90) - Drugs in Development, 2021 SUMMARY Heat Shock Protein 90 (HSP90) - Drugs in Development, 2021 provides in depth analysis on Heat Shock Protein 90 (HSP90) targeted pipel...
April 2021
80 pages
Hemagglutinin 5 (H5) - Drugs in Development, 2021
US$ 3,000.00
Hemagglutinin 5 (H5) - Drugs in Development, 2021 SUMMARY Hemagglutinin 5 (H5) - Drugs in Development, 2021 provides in depth analysis on Hemagglutinin 5 (H5) targeted pipeline therapeutics. The repor...
April 2021
30 pages
Hematological Tumor (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Hematological Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Hematological Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Hematological Tumor pipeline landscape. The...
April 2021
425 pages
Heme Polymerase (EC 2.0.0.0) - Drugs in Development, 2021
US$ 3,000.00
Heme Polymerase (EC 2.0.0.0) - Drugs in Development, 2021 SUMMARY Heme Polymerase (EC 2.0.0.0) - Drugs in Development, 2021 provides in depth analysis on Heme Polymerase (EC 2.0.0.0) targeted pipeline...
April 2021
30 pages
